Growth Hormone Treatment Study in Children With Cystic Fibrosis
Status:
Withdrawn
Trial end date:
2018-12-12
Target enrollment:
Participant gender:
Summary
Cystic fibrosis (CF) is a catabolic condition, and children affected with this disease
frequently have problems with growth, despite adequate nutrition. We hypothesize that the
anabolic effects of growth hormone (GH) will improve the height and weight of CF patients and
thereby improve their clinical status and their quality of life. We further hypothesize that
these effects will be sustained for at least one year after GH treatment is complete.